Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study-Reference-Cited by-同舟云学术

Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study

Published:2018-04-10 Issue:1 Volume:20 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Zhou Yang-zhong,Zhao Li-dan,Chen Hua,Zhang Yan,Wang Dan-feng,Huang Lin-fang,Lv Qian-wen,Liu Bin,Li Zhenbin,Wei Wei,Li Hongbin,Liao Xiangping,Liu Hui,Liu Xiumei,Jin Hongtao,Wang Junxiang,Fei Yun-yun,Wu Qing-jun,Zhang Wen,Shi Qun,Zheng Wen-jie,Zhang Feng-chun,Tang Fu-lin,Lipsky Peter E.,Zhang Xuan^ORCID

Funder

National Natural Science Foundation of China

Chinese Academy of Medical Science Innovation Fund for Medical Sciences

National Key Research and Development Program: “Precise Medical Research”

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-018-1563-6.pdf

Reference37 articles.

1. Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet (London, England). 2010;376:1094–108.

2. O’Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013;369:307–18.

3. Finckh A, Bansback N, Marra CA, Anis AH, Michaud K, Lubin S, et al. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med. 2009;151:612–21.